Hostname: page-component-78c5997874-4rdpn Total loading time: 0 Render date: 2024-11-17T14:55:15.376Z Has data issue: false hasContentIssue false
  • English
  • Français

Proliferation Kinetics of Acute Leukemia Cells in Relation to the Chemotherapy1

Published online by Cambridge University Press:  01 August 2014

F. Gavosto ,
A. Pileri  and
L. Pegoraro
F. Gavosto
Affiliation:
Istituto di Clinica Medica Generale e Terapia Medica della Università, Torino
A. Pileri
Affiliation:
Istituto di Clinica Medica Generale e Terapia Medica della Università, Torino
L. Pegoraro
Affiliation:
Istituto di Clinica Medica Generale e Terapia Medica della Università, Torino

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The proliferative characteristics of human acute leukaemia cells are reported and the relationships between the proliferative alterations and differentiation defect of these cells discussed. The proliferative activity of acute leukaemia cells was also studied in relation to cytostatic treatment.

Emphasis is laid on the fact that in all cases of acute leukaemia the characteristic blast cells of the disease do not constitute a homogenous cell population but can be divided into various sub-classes with different kinetic and proliferative characteristics. It is also pointed out that all cytostatic treatment acts on the most actively proliferating classes and only indirectly on the non-proliferating classes.

Finally, the need for more detailed study of DNA synthesis at chromosome and sub-chromosome level for the purpose of more fully understanding the response of leukaemic cells to the various chemiotherapies is underlined.

Type
Research Article
Information
Acta geneticae medicae et gemellologiae: twin research , Volume 17 , Issue 1 , January 1968 , pp. 30 - 39
Copyright
Copyright © The International Society for Twin Studies 1967

Footnotes

1

Work supported by Euratom (contracts 016-62-1 BIOI and 061-66-3 BIOI) and by C.N.R. (Rome).

References

Astaldi, G., Mauri, C. (1950). New criteria for the evaluation of the bone marrow cells mitotic activity. Le Sang 21: 378.Google Scholar
Astaldi, G., Mauri, C. (1953). Recherches sur l'activité proliferative de l'hémocytoblaste de leucémie aigué. Rev. Belg. Path. 23: 69.Google Scholar
Bond, V. P. et al. (1959). Proliferative potential of bone marrow and blood cells studied by in vitro uptake of H3 thymidine. Acta Haemat. 21: 1.Google Scholar
Bond, V. P. et al. (1962). Study of the effect of therapy on cells in the blood of leukemic patients capable of incorporating H3 thymidine. J. Lab. Clin. Invest. 59: 412.Google Scholar
Dogliotti, G. C., Pileri, A. (1966). Chemioterapia e potenzialità proliferativa degli elementi leucemici. Minerva Med. 57: 1086.Google Scholar
Gavosto, F. (1962). Nucleic acids and protein metabolism of bone marrow cells studied by means of tritium-labelled precursors. Proc. Symp. Tritium in the Phys. Biol. Sci., 2: 237 (Intern. Atomic Energy Agency, Vienna).Google Scholar
Gavosto, F. (1965). Leucemie e differenziazione cellulare. Haemat. Lat. 8: 213.Google Scholar
Gavosto, F. et al. (1959). Incorporazione di timidina marcata con tritio negli elementi del midollo osseo normale e leucemico. Indagini autoradiografiche. Haemat. 44: 977.Google Scholar
Gavosto, F. et al. (1960). Nucleic acids and protein metabolism in acute leukaemia cells. Blood 16: 1555.CrossRefGoogle Scholar
Gavosto, F. et al. (1960). Proliferative capacity of acute leukaemia cells. Nature 187: 611.Google Scholar
Gavosto, F. et al. (1963). In vivo incorporation of tritiated thymidine in acute leukaemia chromosomes. Nature 200: 807.Google Scholar
Gavosto, F. et al. (1964). Proliferation and maturation defect in acute leukaemia cells. Nature 203: 92.Google Scholar
Gavosto, F. et al. (1965). Ricerche in vivo sul metabolismo dell'RNA negli elementi di leucemia acuta umana. Tumori 51: 419.Google Scholar
Gavosto, F. et al. (1965). Thymidine Incorporation in the Chromosomes of Human Acute Leukaemia. Current Res. in Leukaemia. Cambridge Univ. Press.Google Scholar
Keidan, S. E. (1964). Prolonged remission in acute leukaemia. Brit. Med. J. 2: 1430.Google Scholar
Killman, S. A. (1965). Proliferative activity of blast cells in leukaemia and myelofibrosis. Acta Med. Scand. 178: 263.Google Scholar
Killman, S. A. et al. (1963). Estimation of phases of the life cycle of leukemic cells from labelling in human beings in vivo with tritiated thymidine. Lab. Invest. 12: 671.Google Scholar
Mauer, A. M., Fisher, V. (1962). Comparison of the proliferative capacity of acute leukaemia cells in bone marrow and blood. Nature 193: 1085.Google Scholar
Mauer, A. M., Fisher, V. (1963). In vivo study of cell kinetics in acute leukaemia. Nature 197: 574.Google Scholar
Milton, J. O., Cooper, E. H. (1964). Metabolism of thymidine and deoxycytidine-51-monophosphate by leukocytes in vitro. Biochem. J. 93: 14.Google Scholar
Pileri, A. et al. (1964). Pouvoir proliférant des éléments blastiques leucémiques. Sangre 9: 320.Google Scholar
Pileri, A. et al. (1965). Studio della capacità proliferativa delle cellule sanguigne mediante l'impiego di acido desossicitidilico in luogo di timidina. Boll. Soc. Hai. Biol. Sper. 49: 744.Google Scholar
Sandberg, A. A. (1965). Chromosomes and leukemia. Internai. Symp. Cytogenet. Leuk. Atti Convegno Farmitalia, Torino 1965.Google Scholar
Zuelzer, W. W. (1964). Implications of long-term survival in acute stem cell leukemia of childhood treated with composite cyclic therapy. Blood 24: 477.Google Scholar